Explore 3 Stock Ideas & Industry Insights Download Free Report

Tecan Group AG

Company price
242.4 GBX -2.30 ( 0.94%)
Last update at 2026-10-27T16:19:00Z
VOLUME
2939
Market Cap
1556.43M
P/E
0.13

Momentum Score

…

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
240.50
Low
246.40
High
52 Week Price Range
111.00
Low
177.55
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
244.70
Dividend Yield
2.21%
Revenue TTM
882.48M
Revenue Per Share
69.69
Gross Profit TTM
310.84M
Debt / Equity
0.19
ROE
-8.56%
Net Debt
41.95M
ROCE
2.99%
Diluted EPS TTM
9.88

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -101.26M 78.28M 133.81M 142.49M 137.93M
Net income -110.65M 67.66M 132.07M 121.13M 121.66M
Selling general administrative - 73.16M 72.05M 81.42M 71.96M
Selling and marketing expenses - 110.17M 119.58M 132.81M 120.11M
Gross profit 310.84M 320.60M 390.47M 438.07M 408.57M
Ebit - 80.99M 134.78M 147.67M 146.34M
Ebitda 42.17M 147.80M 205.57M 187.73M 183.57M
Depreciation and amortization - 66.81M 70.79M 40.05M 37.23M
Operating income 42.17M 75.57M 135.97M 147.67M 146.34M
Other operating expenses 840.31M 858.71M 938.42M 1000.84M 804.62M
Interest expense 9.83M 2.71M 1.33M - 0.00M
Income tax expense 9.40M 10.61M 1.73M 21.36M 16.27M
Total revenue 882.48M 934.28M 1074.39M 1144.26M 946.62M
Total operating expenses 268.67M 245.03M 254.50M 294.65M 266.57M
Cost of revenue 571.64M 613.68M 683.92M 706.19M 538.05M
Total other income expense net -143.43M 2.70M -2.16M -5.19M -8.41M
Net income applicable to common shares - - - 121.13M 121.66M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1698.09M 2121.48M 2073.97M 2116.18M 1996.18M
Intangible assets 259.44M 308.31M 311.27M 313.58M 332.68M
Other current assets 22.24M 24.02M 35.62M 29.39M 29.54M
Total liab 546.60M 686.15M 725.06M 758.46M 771.29M
Total stockholder equity 1151.49M 1435.33M 1348.91M 1357.72M 1224.89M
Deferred long term liab - - - 39.28M 37.99M
Other current liab 223.02M 204.00M 141.07M 302.06M 278.82M
Common stock 1.28M 1.28M 1.28M 1.27M 1.27M
Retained earnings 978.86M 1111.81M 1067.62M 981.48M 858.92M
Other liab - - - 128.71M 164.31M
Good will 553.09M 760.96M 709.95M 775.14M 767.10M
Other assets - - - 70.30M 69.99M
Cash 176.37M 154.19M 132.97M 111.44M 121.01M
Total current liabilities 288.75M 531.25M 296.91M 336.34M 306.37M
Current deferred revenue - - 82.47M - -
Net debt 41.95M 167.15M 183.13M -111.44M -121.01M
Short term debt 10.40M 261.39M 12.24M - -
Short long term debt total 218.32M 321.35M 316.09M - -
Other stockholder equity 171.35M -28.93M - 374.97M 364.70M
Property plant equipment - - - 149.41M 150.33M
Total current assets 711.74M 856.31M 850.57M 803.53M 671.86M
Net tangible assets - - - 269.00M 125.12M
Short term investments 135.00M 251.81M 233.46M 180.00M 120.00M
Net receivables 165.56M 195.78M 194.17M 182.12M 152.20M
Inventory 212.57M 230.50M 254.37M 300.59M 249.11M
Accounts payable 27.82M 33.61M 39.20M 34.28M 27.55M
Accumulated other comprehensive income - 351.17M 280.02M - -
Non currrent assets other 2.22M 253.20M 234.81M -1242.35M -1254.33M
Non current assets total 986.35M 1265.18M 1223.39M 1242.35M 1254.33M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - -60.00M 195.88M
Change to liabilities - - - 19.49M 6.16M
Total cashflows from investing activities 76.50M -48.61M -84.23M -88.19M -651.92M
Net borrowings - - - -13.77M 130.41M
Total cash from financing activities -187.48M -81.30M -50.57M -48.65M 454.48M
Change to operating activities - - - 10.39M -13.21M
Net income -110.65M 67.66M 132.07M 121.13M 121.66M
Change in cash 22.18M 21.23M 21.52M -9.56M -27.43M
Begin period cash flow 154.19M 132.97M 111.44M 121.01M 148.44M
End period cash flow 176.37M 154.19M 132.97M 111.44M 121.01M
Total cash from operating activities 137.98M 148.54M 160.57M 128.28M 169.85M
Depreciation 60.99M 66.81M 70.79M 54.93M 49.47M
Other cashflows from investing activities -16.29M -10.39M -26.62M 7.99M 5.04M
Dividends paid 38.03M 38.32M 37.02M 35.60M 27.61M
Change to inventory 1.39M 35.48M 29.47M -54.16M -43.93M
Change to account receivables 10.27M 13.82M -13.45M -30.32M 26.63M
Sale purchase of stock -33.41M -28.93M 1.45M - -
Other cashflows from financing activities -15.96M -15.40M -14.73M 0.72M 601.13M
Change to netincome - - - -5.30M 13.51M
Capital expenditures 35.30M 30.68M 34.94M 23.07M 27.14M
Change in working capital 31.86M 27.68M -18.30M -84.48M -17.30M
Stock based compensation 3.07M 4.09M 14.82M 13.85M 12.90M
Other non cash items 152.70M -17.70M -4.99M 22.85M 3.13M
Free cash flow 102.67M 117.86M 125.63M 105.20M 142.72M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0QLN
Tecan Group AG
-2.30
0.94%
242.40 0.13 - 1.76 -
0R15
SoftBank Group Corp.
248.00
5.84%
4494.00 - - - -
0R1E
Nintendo Co. Ltd.
-115.00
1.34%
8476.00 - - - -
0LC3
Synchrony Financial
2.34
3.20%
75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A
0.15
0.12%
122.47 0.25 - 1.18 -

Profile*

Tecan Group AG

Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments: Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, sequencing reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service. Tecan Group AG has a strategic collaboration with NVIDIA Corporation to develop AI-enabled platform for data-driven laboratories to help discoveries and lab productivity. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.

Seestrasse 103, Männedorf, Switzerland, 8708

41 44 922 81 11

3026

Name Title Year Born
Dr. Achim von Leoprechting Ph.D. CEO & Member of Management Board 1968
Ms. Tania Micki B.A., M.B.A. CFO & Member of Management Board 1971
Mr. Gunter Weisshaar Sr. VP, Head of Quality Assurance & Regulatory Affairs and Member of Management Board 1960
Mr. Andreas Wilhelm Exec. VP, Gen. Counsel, Sec. of the Board of Directors & Member of Management Board 1969
Mr. Martin Brandle Sr. VP of Corp. Communications & Investor Relations and Member of Management Board NA
Dr. Klaus Lun M.B.A., M.Sc., Ph.D. Exec. VP, Member of Management Board & Head of the Life Sciences Bus. Division 1972
Dr. Ulrich Kanter Exec. VP, Global Head of Operations & IT and Member of Management Board 1963
Mr. Erik Norström B.Sc., M.Sc. Head of Corp. Devel., Exec. VP & Member of Management Board 1973
Dr. Wael Yared CTO, Exec. VP, Head R&D & Member of the Management Board 1962
Mr. Ralf Griebel Exec. VP, Head of the Partnering Bus. Division & Member of the Management Board 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…